Evidence map›Paper›PMID 25133096›Full record

ArticleTranslational andrology and urology2012

TGF-β mediated DNA methylation in prostate cancer.

Chung Lee, Qiang Zhang, Xaolin Zi, Atreya Dash, Marcelo B Soares, Farahnaz Rahmatpanah, Zhenyu Jia, Michael McClelland, Dan Mercola

Open access · greenAbstract read
In one paragraph

Article in Translational andrology and urology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. TGF-β1 epigenetically modifies Thy-1 expression in primary lung fibroblasts.American journal of physiology. Cell physiology · 2015
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Chung LeeThe Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA ; Department of Urology, the University of California at Irvine, CA 92868, USA ; The Department of Pathology and Laboratory Medicine, the University of California at Irvine, CA 92697, USA.
Qiang ZhangThe Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Xaolin ZiDepartment of Urology, the University of California at Irvine, CA 92868, USA.
Atreya DashDepartment of Urology, the University of California at Irvine, CA 92868, USA.
Marcelo B SoaresCancer Biology and Epigenomics Program, Children's Memorial Research Center, Chicago IL 60614, USA.
Farahnaz RahmatpanahThe Department of Pathology and Laboratory Medicine, the University of California at Irvine, CA 92697, USA.
Zhenyu JiaThe Department of Pathology and Laboratory Medicine, the University of California at Irvine, CA 92697, USA.
Michael McClellandThe Department of Pathology and Laboratory Medicine, the University of California at Irvine, CA 92697, USA.
Dan MercolaThe Department of Pathology and Laboratory Medicine, the University of California at Irvine, CA 92697, USA.
Northwestern University · US

Funding

SUPPRESSIVE ROLE OF ANDROGEN RESPONSE GENE CALRETICULIN IN PROSTATE CANCERP50CA090386 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CRAWFORD, SUSAN · 2001 to 2013
$25.1M
CARCINOGENESIST32CA009054 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI EDINGER, AIMEE L, FRUMAN, DAVID ALEXANDER · 1985 to 2025
$8.6M
Evaluation of Predictive Signatures of Prostate CancerU01CA114810 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI MERCOLA, DAN · 2005 to 2009
$8.2M
The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed GeneU01CA152738 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI LEE, CHUNG, MERCOLA, DAN · 2010 to 2015
$3.6M
NCI NIH HHS P50 CA090386NCI NIH HHS T32 CA009054NCI NIH HHS U01 CA114810NCI NIH HHS U01 CA152738
6 · The paper itself

Abstract

Almost all tumors harbor a defective negative feedback loop of signaling by transforming growth factor-β (TGF-β). Epigenetic mechanisms of gene regulation, including DNA methylation, are fundamental to normal cellular function and also play a major role in carcinogenesis. Recent evidence demonstrated that TGF-β signaling mediates cancer development and progression. Many key events in TGF-β signaling in cancer included auto-induction of TGF-β1 and increased expression of DNA methyltransferases (DNMTs), suggesting that DNA methylation plays a significant role in cancer development and progression. In this review, we performed an extensive survey of the literature linking TGF-β signaling to DNA methylation in prostate cancer. It appeared that almost all DNA methylated genes detected in prostate cancer are directly or indirectly related to TGF-β signaling. This knowledge has provided a basis for our future directions of prostate cancer research and strategies for prevention and therapy for prostate cancer.

Indexed as

DNA methylationDNMTErk activationprostate cancerTGF-βtumor development and progression

Identifiers

PMID25133096
PMCPMC4131550
OpenAlexW67968860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.